Targeting Vascular Endothelial Growth Factor Pathway in First-Line Treatment of Metastatic Colorectal Cancer: State-of-the-Art and Future Perspectives in Clinical and Molecular Selection of Patients

By  

Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-02 ,pp. : 37-45

Bentham Science Publishers

Access to resources Recommend Favorite

ZD1839: targeting the epidermal growth factor receptor in cancer therapy

By Herbst Roy S  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 837-849

Informa Healthcare

Access to resources Recommend Favorite

Beyond RAS: The Role of Epidermal Growth Factor Receptor (EGFR) and its Network in the Prediction of Clinical Outcome During Anti-EGFR Treatment in Colorectal Cancer Patients

By  

Current Drug Targets, Vol. 15, Iss. 13, 2014-12 ,pp. : 1225-1230

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Approaches for the Treatment of Epidermal Growth Factor Receptor Mutated Lung Cancer

By  

Current Cancer Drug Targets, Vol. 18, Iss. 8, 2018-10 ,pp. : 773-791

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibodies Targeting the Epidermal Growth Factor Receptor

By  

Current Drug Targets, Vol. 6, Iss. 3, 2005-05 ,pp. : 275-287

Bentham Science Publishers

Access to resources Recommend Favorite